Efficacy and Safety of GLP ‐1 and Dual GIP / GLP ‐1 Receptor Agonists in Idiopathic Intracranial Hypertension: A Systematic Review and Meta‐Analysis
Open accessAbstract
Background: Repurposing glucagon‐like peptide‐1 (GLP‐1) and GIP/GLP‐1 receptor agonists (RAs) for idiopathic intracranial hypertension (IIH) represents an attractive alternative to current treatments, supported by evidence of potent metabolic effects and reductions in cerebrospinal fluid secretion and intracranial pressure in vivo. Methods: We evaluated the safety and efficacy of GLP‐1 RAs and GIP/GLP‐1 RAs in IIH. MEDLINE and Scopus databases were searched for randomized‐controlled trials (RCT), non‐randomized clinical trials, or registries in adults with IIH. Results: Two clinical trials (one RCT and one non‐randomized case–control) and two registries, comprising 1550 IIH patients (768 receiving GLP‐1 or GIP/GLP‐1 RAs) were included. Compared with standard‐of‐care, GLP‐1 or GIP/GLP‐1 RAs were associated with a significantly lower risk of papilledema (RR: 0.25; 95% CI: 0.15–0.43; p < 0.01) and visual disturbances or blindness (RR: 0.41; 95% CI: 0.18–0.92; p = 0.03), and a near‐significant trend toward reduced headache risk (RR: 0.61; 95% CI: 0.34–1.07; p = 0.08). Additionally, GLP‐1 RAs significantly reduced monthly headache days at 3 months (MD = −3.64; 95% CI: −6.26 to −1.03; p < 0.01) and at the end of follow‐up (MD = −4.82; 95% CI: −8.80 to −0.85; p = 0.02). No association was detected between GLP‐1 RAs and body mass index. No serious adverse events or treatment discontinuations were reported; mild gastrointestinal adverse events and nausea occurred in 88% (95% CI: 0.46–1.00) of GLP‐1 RA‐treated patients. Conclusions: GLP‐1 and dual GIP/GLP‐1 RAs are associated with a significantly lower risk of papilledema and visual disturbances or blindness and a lower headache risk compared with standard‐of‐care. Additionally, GLP‐1 RAs significantly reduce the monthly headache burden. Well‐designed RCTs are needed to robustly evaluate the effects of GLP‐1 and GIP/GLP‐1 RAs in IIH, which likely extend beyond their weight‐loss‐inducing properties. Trial Registration: PROSPERO registration ID: CRD42025650082
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dual GIP/GLP-1 receptor agonists have shown potential benefits in IIH management, possibly through reduced CSF secretion and intracranial pressure.
“Dual GIP/GLP-1 receptor agonists have likewise shown potential benefits in IIH management, possibly through reduced CSF secretion and intracranial pressure.43”
From Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis (2025) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 33,583 · see citing works
Statistical Power Analysis for the Behavioral Sciences
Cohen, J. (2013) · doi:10.4324/9780203771587 · Cited by 25,373 · see citing works
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329 · see citing works
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735 · cited 1× · see citing works
“For studies reporting continuous outcomes in median values and corresponding inter-quartile ranges, we estimated the sample mean and standard deviation using the quantile estimation method [21].”
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578 · see citing works
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432 · see citing works
Analysing data and undertaking meta‐analyses
Deeks, J. J., Higgins, J. P., Altman, D. G., & on behalf of the Cochrane Statistical Methods Group (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch10 · Cited by 2,672 · see citing works
Transformations Related to the Angular and the Square Root
Freeman, M. F., & Tukey, J. W. (1950) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177729756 · Cited by 2,634 · see citing works
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children
Friedman, D. I., Liu, G. T., & Digre, K. B. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a55f17 · Cited by 1,492 · see citing works
Tepper, S. J., Ashina, M., Reuter, U., Brandes, J. L., Doležil, D., Silberstein, S. D., Winner, P. K., Leonardi, D. K., Mikol, D. D., & Lenz, R. A. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30083-2 · Cited by 722 · see citing works
Idiopathic intracranial hypertension: consensus guidelines on management
Mollan, S. P., Davies, B., Silver, N. C., Shaw, S., Mallucci, C. L., Wakerley, B. R., Krishnan, A., Chavda, S. V., Ramalingam, S., Edwards, J. A., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317440 · Cited by 617 · see citing works
Wall, M., McDermott, M., Kieburtz, K. D., Corbett, J. J., Feldon, S. E., Friedman, D. I., Katz, D. M., Keltner, J. L., SCHRON, E. B., & Kupersmith, M. J. (2014) · JAMA · doi:10.1001/jama.2014.3312 · Cited by 548 · see citing works
Sinclair, A. J., Burdon, M., Nightingale, P., Ball, A. K., Good, P. A., Matthews, T. D., Jacks, A. S., Lawden, M., Clarke, C. E., Stewart, P. M., et al. (2010) · BMJ · doi:10.1136/bmj.c2701 · Cited by 349 · see citing works
Epidemiology and Risk Factors for Idiopathic Intracranial Hypertension
Chen, J. L., & Wall, M. (2013) · International Ophthalmology Clinics · doi:10.1097/iio.0b013e3182aabf11 · Cited by 203 · see citing works
European Headache Federation guideline on idiopathic intracranial hypertension
Hoffmann, J., Mollan, S. P., Paemeleire, K., Lampl, C., Jensen, R., & Sinclair, A. J. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0919-2 · Cited by 186 · see citing works
Botfield, H. F., Uldall, M., Westgate, C. S. J., Mitchell, J., Hagen, S. M., Gonzalez, A. M., Hodson, D. J., Jensen, R., & Sinclair, A. J. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan0972 · Cited by 164 · see citing works
The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
Mitchell, J., Lyons, H., Walker, J. K., Yiangou, A., Grech, O., Alimajstorovic, Z., Greig, N., Li, Y.-Z., Tsermoulas, G., Brock, K., et al. (2023) · Brain : a journal of neurology · doi:10.1093/brain/awad003 · Cited by 159 · see citing works
Interventions for idiopathic intracranial hypertension
Piper, R. J., Kalyvas, A., Young, A. M. H., Hughes, M. A., Jamjoom, A. A. B., & Fouyas, I. P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003434.pub3 · Cited by 141 · see citing works
McCluskey, G., Doherty‐Allan, R., McCarron, P., Loftus, A. M., McCarron, L. V., Mulholland, D. A., McVerry, F., & McCarron, M. O. (2018) · European Journal of Neurology · doi:10.1111/ene.13739 · Cited by 119 · see citing works
Incidence, Prevalence, and Health Care Outcomes in Idiopathic Intracranial Hypertension
Miah, L., Strafford, H., Fonferko‐Shadrach, B., Hollinghurst, J., Sawhney, I. M. S., Hadjikoutis, S., Rees, M. I., Powell, R., Lacey, A., & Pickrell, W. O. (2021) · Neurology · doi:10.1212/wnl.0000000000011463 · Cited by 95 · see citing works
Krajnc, N., Itariu, B. K., Macher, S., Marik, W., Harreiter, J., Michl, M., Novak, K., Wöber, C., Pemp, B., & Bsteh, G. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01631-z · Cited by 84 · see citing works
Advances in the understanding of headache in idiopathic intracranial hypertension
Mollan, S. P., Hoffmann, J., & Sinclair, A. J. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000651 · Cited by 82 · see citing works
Thaller, M., Homer, V., Hyder, Y. F., Yiangou, A., Anthony, L., Fong, A. W., Virdee, J. S., Piccus, R., Roque, M., Mollan, S. P., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11402-6 · Cited by 68 · see citing works
Halloum, W., Dughem, Y. A., Beier, D., & Pellesi, L. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01821-3 · Cited by 63 · see citing works
Stefanou, M.-I., Theodorou, A., Malhotra, K., Aguiar de Sousa, D., Katan, M., Palaiodimou, L., Katsanos, A. H., Koutroulou, I., Lambadiari, V., Lemmens, R., et al. (2024) · European Stroke Journal · doi:10.1177/23969873241234238 · Cited by 60 · see citing works
Self-citationShaia, J. K., Sharma, N., Kumar, M., Chu, J., Maatouk, C. M., Talcott, K. E., Singh, R. P., & Cohen, D. A. (2024) · Neurology · doi:10.1212/wnl.0000000000208036 · Cited by 49 · see citing works
GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
Sioutas, G. S., Mualem, W., Reavey-Cantwell, J. F., & Rivet, D. J. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.2020 · Cited by 48 · see citing works
Weight Management Interventions for Adults With Idiopathic Intracranial Hypertension
Abbott, S., Chan, F., Tahrani, A. A., Wong, S. H., Campbell, F. E. J., Parmar, C. D., Pournaras, D. J., Denton, A., Sinclair, A. J., & Mollan, S. P. (2023) · Neurology · doi:10.1212/wnl.0000000000207866 · Cited by 46 · see citing works
Yiangou, A., Mitchell, J., Nicholls, M., Chong, Y. J., Vijay, V., Wakerley, B. R., Lavery, G. G., Tahrani, A. A., Mollan, S. P., & Sinclair, A. J. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10700-9 · Cited by 41 · see citing works
Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension
Mitchell, J., Mollan, S. P., Vijay, V., & Sinclair, A. J. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000690 · Cited by 37 · see citing works
Stefanou, M.-I., Palaiodimou, L., Theodorou, A., Safouris, A., Fischer, U., Kelly, P. J., Dawson, J., Katan, M., Katsanos, A. H., Lambadiari, V., et al. (2024) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864241281903 · Cited by 36 · see citing works
Self-citationGrech, O., Mitchell, J., Lyons, H., Yiangou, A., Thaller, M., Tsermoulas, G., Brock, K., Mollan, S. P., & Sinclair, A. J. (2024) · Eye · doi:10.1038/s41433-023-02908-y · Cited by 31 · see citing works
Go, E. J., Hwang, S.-M., Jo, H., Rahman, M. M., Park, J., Lee, J. Y., Jo, Y. Y., Lee, B.-G., Jung, Y., Berta, T., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01342-8 · Cited by 28 · see citing works
Luan, S., Cheng, W., Wang, C., Gong, J., & Zhou, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1047883 · Cited by 25 · see citing works
Salmen, T., Șerbănoiu, L. I., Bica, I.-C., Serafinceanu, C., Muzurović, E. M., Janež, A., Busnatu, Ș., Banach, M., Rizvi, A. A., Rizzo, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119760 · Cited by 22 · see citing works
Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines
Palaiodimou, L., Stefanou, M.-I., Katsanos, A., de Sousa, D. A., Coutinho, J., Lagiou, P., Michopoulos, I., Naska, A., Giannopoulos, S., Vadikolias, K., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012896 · Cited by 17 · see citing works
Self-citationStefanou, M., Palaiodimou, L., Katsanos, A. H., Milionis, H. J., Kosmidou, M. S., Lambadiari, V., Halvatsiotis, P., Ferentinos, P. P., Andreadou, E., Marinos, G., et al. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103395 · Cited by 17 · see citing works
Self-citationAzzam, A. Y., Essibayi, M. A., Farkas, N., Azab, M. A., Morsy, M. M., Elamin, O., Elswedy, A., Zomia, A. S. A., Alotaibi, H. A., Alamoud, A., et al. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70019 · Cited by 17 · see citing works
Mitchell, J., Lyons, H., Walker, J. K., Yiangou, A., Thaller, M., Grech, O., Alimajstorovic, Z., Tsermoulas, G., Brock, K., Mollan, S. P., et al. (2025) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14897 · Cited by 16 · see citing works
Siriyotha, S., Anothaisintawee, T., Looareesuwan, P., Nimitphong, H., McKay, G. J., Attia, J., & Thakkinstian, A. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-086424 · Cited by 9 · see citing works
Bakola, E., Palaiodimou, L., Eleftheriou, A., Foska, K., Pikouli, A., Stefanatou, M., Chondrogianni, M. E., Velonakis, G., Andreadou, E., Papadopoulou, Μ., et al. (2023) · Journal of Neuroimaging · doi:10.1111/jon.13160 · Cited by 7 · see citing works
Self-citationOptic disc drusen mimicking Idiopathic Intracranial Hypertension (IIH): rely on ultrasound
Bakola, E., Alonistiotis, D. A., Arvaniti, C., Salakou, S., Nana, N., Foska, A., Kotsali-Peteinelli, V., Voumvourakis, K. I., & Tsivgoulis, G. K. (2021) · Neurological Research and Practice · doi:10.1186/s42466-021-00133-0 · Cited by 6 · see citing works
Self-citationFoska, A., Palaiodimou, L., Stefanou, M., Alonistiotis, D. A., Bakola, E., Papagiannopoulou, G., Arvaniti, C., Bonakis, A., Lachanis, S. B., & Tsivgoulis, G. K. (2022) · The Neurohospitalist · doi:10.1177/19418744221131918 · Cited by 2 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [11]A. Örgel, B. Bender, M. I. Stefanou, H. Hurth, T. K. Hauser, and M. Horger, “ Image Findings in Spontaneous Intracranial Hypotension (SIH),” Röfo 190 (2018): 219– 224. 29495052
Cited by
Sorted by citations
Tzang, C.-C., Wu, P.-H., Luo, C.-A., Chen, Z.-T., Lee, Y.-T., Huang, E. S., Kang, Y.-F., Lin, W.-C., Tzang, B.-S., & Hsu, T.-C. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103680 · Cited by 73 · see citing works
“43 Meta-analyses confirm that GLP-1 and dual GIP/GLP-1 receptor agonists significantly lower major adverse cardiovascular events (MACE) and mortality during active therapy.”
Ahmed, W., Gandhi, O. H., Yu, N. S., Brant, J. A., Hwa, T. P., Bagley, L. J., Tamhankar, M. A., Feroze, A. H., & Choudhri, O. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.125711 · Cited by 8 · see citing works
Effects of GLP-1 receptor agonists on vascular dementia: a systematic review and meta-analysis
Stefanou, M., Tentolouris, A., Panagiotopoulos, E., Theodorou, A., Mengel, A., Athanasaki, A., Lambadiari, V., Peppa, Μ., Papadopoulou, Μ., Παρασκευάς, Γ. Π., et al. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109271 · Cited by 5 · see citing works
Self-citationShah, T., Dougherty, C. O., Ailani, J., & Kerrigan, T. (2026) · Headache The Journal of Head and Face Pain · doi:10.1111/head.70152 · Cited by 2 · see citing works
Meng, Y., Jin, T., Ren, L., Thompson, M. L., & Wang, Y. (2025) · Journal of Clinical Question · doi:10.69854/jcq.2025.0033 · Cited by 1 · see citing works
Al-Harbi, F. A., Alkuwaiti, M. A., Alaql, Y. B., Alsaif, A. K., Alessa, A. A., Alharbi, M., Alfalah, M., Alnaaim, S. A., AlHaddad, S. M., & Azzam, A. Y. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70406 · Cited by 1 · see citing works
Benabdelhak, A., Javidi, E., & Ospina, L. H. (2026) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2026.01.013
Anisman, E. J., Mandloi, S., Alani, A., Kaplan, Z., Bitner, B. F., D’Souza, G. E., Alapati, R., Shing, S. R., Benedict, P. A., Bray, D., et al. (2026) · Neurosurgery · doi:10.1227/neu.0000000000004108
The adipose organ–capacitor model of preclinical and clinical obesity
Nisoli, E. (2026) · Trends Open · doi:10.1016/j.treopn.2026.07.013
Odonkor, C. A., Dodurgali, M. R., Cox, F. R., Klimov, I. J., & Abd-Elsayed, A. A. (2026) · Nutrients · doi:10.3390/nu18193120
Li, H., Peng, S., & Lei, D. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1957367
Roy, J. M., El-Hajj, V. G., Musmar, B., Garg, A., Pontarelli, M.-K., Ellens, N. R., Kim, W. J., Tjoumakaris, S. I., Gooch, M. R., Rosenwasser, R. H., et al. (2026) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2026.109659
- Authors
- Stefanou, M., Chatziralli, I., Lambadiari, V., Mengel, A., Foska, A., Chondrogianni, M., Bakola, E., Tsalouchidou, P., Mitsikostas, D. D., Siasos, G., Ziemann, U., & Tsivgoulis, G.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Hertie Institute for Clinical Brain Research (DE)
- Corresponding author
- Tsivgoulis, Georgios
- ORCID
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2025-09
- Volume
- 32
- Issue
- 9
- Pages
- e70358-e70358
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- PMC
- PMC12426903
- OpenAlex
- W4414160281
- Cited by
- 12
- References
- 43
- Citations by year
- 2026: 9 · 2025: 3
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- European Journal of Neurology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Universitätsbibliothek Tübingen
- Funders
- Eberhard Karls Universität Tübingen
- Topics
- Health Sciences › Medicine › Neurology › Cerebral Venous Sinus Thrombosis
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Migraine and Headache Studies
- Keywords
- idiopathic intracranial hypertension, GLP-1 receptor agonists, GIP/GLP-1 receptor agonist, drug repurposing, papilledema, visual disturbances, headache, intracranial pressure, cerebrospinal fluid production, body mass index, gastrointestinal adverse effects, treatment efficacy and safety, drug interactions with anticoagulants
- MeSH terms
- Glucagon-Like Peptide-1 Receptor Agonists, Gastric Inhibitory Polypeptide, Humans, Pseudotumor Cerebri, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
